Search research articles
Contact Us
Filters
Showing results (61-70 of 150) with videos related to
Page
of 15
Sort By:
Anti-Cancer Drugs
|
October 19, 2000
The clinical pharmacology of alkylating agents in high-dose chemotherapy
A D Huitema, K D Smits, R A Mathôt, et al.
Clinical Pharmacology and Therapeutics
|
June 29, 2000
Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods
A D Huitema, R A Mathôt, M M Tibben, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin
L J van Warmerdam, S Rodenhuis, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 1998
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
A M Westermann, E Havik, F R Postma, et al.
British Journal of Haematology
|
December 1, 1985
Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
O A van Dobbenburgh, S Rodenhuis, T Ockhuizen, et al.
European Journal of Clinical Pharmacology
|
November 9, 2001
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma
T Kerbusch, R A Mathĵt, H J Keizer, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen
V R Panday, L J van Warmerdam, M T Huizing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study
G Stoter, S Aamdal, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study
S Rodenhuis, L Boerrigter, B Top, et al.
Blood
|
February 7, 2001
In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation
C Voermans, M L Kooi, S Rodenhuis, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 150) with videos related to
Sort By:
Page
of 15
Anti-Cancer Drugs
|
October 19, 2000
The clinical pharmacology of alkylating agents in high-dose chemotherapy
A D Huitema, K D Smits, R A Mathôt, et al.
Clinical Pharmacology and Therapeutics
|
June 29, 2000
Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods
A D Huitema, R A Mathôt, M M Tibben, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin
L J van Warmerdam, S Rodenhuis, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 1998
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
A M Westermann, E Havik, F R Postma, et al.
British Journal of Haematology
|
December 1, 1985
Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
O A van Dobbenburgh, S Rodenhuis, T Ockhuizen, et al.
European Journal of Clinical Pharmacology
|
November 9, 2001
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma
T Kerbusch, R A Mathĵt, H J Keizer, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 1999
A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen
V R Panday, L J van Warmerdam, M T Huizing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study
G Stoter, S Aamdal, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study
S Rodenhuis, L Boerrigter, B Top, et al.
Blood
|
February 7, 2001
In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation
C Voermans, M L Kooi, S Rodenhuis, et al.
Page
of 15